Characterization  ||| S:0 E:17 ||| NN
of  ||| S:17 E:20 ||| IN
estrogens ||| S:20 E:29 ||| NN
,  ||| S:29 E:31 ||| ,
testosterone ||| S:31 E:43 ||| NN
,  ||| S:43 E:45 ||| ,
and  ||| S:45 E:49 ||| CC
cortisol  ||| S:49 E:58 ||| NN
in  ||| S:58 E:61 ||| IN
normal  ||| S:61 E:68 ||| JJ
bottlenose  ||| S:68 E:79 ||| JJ
dolphin  ||| S:79 E:87 ||| NNS
( ||| S:87 E:88 ||| -LRB-
Tursiops  ||| S:88 E:97 ||| UH
truncatus ||| S:97 E:106 ||| UH
)  ||| S:106 E:108 ||| -RRB-
pregnancy  ||| S:108 E:118 ||| NN
The  ||| S:118 E:122 ||| DT
goal  ||| S:122 E:127 ||| NN
of  ||| S:127 E:130 ||| IN
this  ||| S:130 E:135 ||| DT
study  ||| S:135 E:141 ||| NN
was  ||| S:141 E:145 ||| VBD
to  ||| S:145 E:148 ||| TO
describe  ||| S:148 E:157 ||| VB
profiles  ||| S:157 E:166 ||| NNS
of  ||| S:166 E:169 ||| IN
serum  ||| S:169 E:175 ||| JJ
estrogens ||| S:175 E:184 ||| NN
,  ||| S:184 E:186 ||| ,
testosterone  ||| S:186 E:199 ||| NN
and  ||| S:199 E:203 ||| CC
cortisol  ||| S:203 E:212 ||| NN
during  ||| S:212 E:219 ||| IN
normal  ||| S:219 E:226 ||| JJ
pregnancy  ||| S:226 E:236 ||| NN
in  ||| S:236 E:239 ||| IN
bottlenose  ||| S:239 E:250 ||| JJ
dolphins ||| S:250 E:258 ||| NNS
.  ||| S:258 E:260 ||| .
Predominant  ||| S:260 E:272 ||| JJ
estrogens  ||| S:272 E:282 ||| NN
in  ||| S:282 E:285 ||| IN
all  ||| S:285 E:289 ||| DT
categories  ||| S:289 E:300 ||| NNS
of  ||| S:300 E:303 ||| IN
dolphin  ||| S:303 E:311 ||| JJ
sera  ||| S:311 E:316 ||| JJ
pools  ||| S:316 E:322 ||| NNS
during  ||| S:322 E:329 ||| IN
estrus  ||| S:329 E:336 ||| NN
and  ||| S:336 E:340 ||| CC
pregnancy  ||| S:340 E:350 ||| NN
( ||| S:350 E:351 ||| -LRB-
EARLY ||| S:351 E:356 ||| NNP
:  ||| S:356 E:358 ||| :
Days  ||| S:358 E:363 ||| NNP
0-120 ||| S:363 E:368 ||| NNP
;  ||| S:368 E:370 ||| :
MID ||| S:370 E:373 ||| NNP
:  ||| S:373 E:375 ||| :
Days  ||| S:375 E:380 ||| NNP
121-240 ||| S:380 E:387 ||| NNP
;  ||| S:387 E:389 ||| :
LATE ||| S:389 E:393 ||| RB
:  ||| S:393 E:395 ||| :
Days  ||| S:395 E:400 ||| NNP
241  ||| S:400 E:404 ||| CD
to  ||| S:404 E:407 ||| TO
parturition ||| S:407 E:418 ||| VB
;  ||| S:418 E:420 ||| :
Day  ||| S:420 E:424 ||| NNP
0=day  ||| S:424 E:430 ||| NNP
of  ||| S:430 E:433 ||| IN
conception ||| S:433 E:443 ||| NN
)  ||| S:443 E:445 ||| -RRB-
were  ||| S:445 E:450 ||| VBD
estrone ||| S:450 E:457 ||| FW
/ ||| S:457 E:458 ||| FW
estrone  ||| S:458 E:466 ||| FW
conjugates  ||| S:466 E:477 ||| FW
( ||| S:477 E:478 ||| -LRB-
E1-C ||| S:478 E:482 ||| NNP
)  ||| S:482 E:484 ||| -RRB-
and  ||| S:484 E:488 ||| CC
estriol  ||| S:488 E:496 ||| NNS
( ||| S:496 E:497 ||| -LRB-
E3 ||| S:497 E:499 ||| NNP
) ||| S:499 E:500 ||| -RRB-
.  ||| S:500 E:502 ||| .
Serum  ||| S:502 E:508 ||| JJ
samples  ||| S:508 E:516 ||| NNS
collected  ||| S:516 E:526 ||| VBN
throughout  ||| S:526 E:537 ||| IN
101  ||| S:537 E:541 ||| CD
normal  ||| S:541 E:548 ||| JJ
pregnancies  ||| S:548 E:560 ||| NN
were  ||| S:560 E:565 ||| VBD
analyzed  ||| S:565 E:574 ||| VBN
for  ||| S:574 E:578 ||| IN
E1-C ||| S:578 E:582 ||| NNP
,  ||| S:582 E:584 ||| ,
E3 ||| S:584 E:586 ||| NNP
,  ||| S:586 E:588 ||| ,
testosterone  ||| S:588 E:601 ||| NNS
( ||| S:601 E:602 ||| -LRB-
T ||| S:602 E:603 ||| NN
)  ||| S:603 E:605 ||| -RRB-
and  ||| S:605 E:609 ||| CC
cortisol  ||| S:609 E:618 ||| NNS
( ||| S:618 E:619 ||| -LRB-
CORT ||| S:619 E:623 ||| NNP
) ||| S:623 E:624 ||| -RRB-
.  ||| S:624 E:626 ||| .
E1-C  ||| S:626 E:631 ||| NNP
was  ||| S:631 E:635 ||| VBD
higher  ||| S:635 E:642 ||| JJR
( ||| S:642 E:643 ||| -LRB-
P  ||| S:643 E:644 ||| NNP
< ||| S:644 E:645 ||| SYM
0.05 ||| S:645 E:649 ||| CD
)  ||| S:649 E:651 ||| -RRB-
during  ||| S:651 E:658 ||| IN
LATE  ||| S:658 E:663 ||| RB
compared  ||| S:663 E:672 ||| VBN
to  ||| S:672 E:675 ||| TO
EARLY  ||| S:675 E:681 ||| NNP
and  ||| S:681 E:685 ||| CC
MID ||| S:685 E:688 ||| NNP
,  ||| S:688 E:690 ||| ,
and  ||| S:690 E:694 ||| CC
higher  ||| S:694 E:701 ||| JJR
( ||| S:701 E:702 ||| -LRB-
P  ||| S:702 E:703 ||| NNP
< ||| S:703 E:704 ||| SYM
0.05 ||| S:704 E:708 ||| CD
)  ||| S:708 E:710 ||| -RRB-
in  ||| S:710 E:713 ||| IN
nulliparous  ||| S:713 E:725 ||| NN
than  ||| S:725 E:730 ||| IN
multiparous  ||| S:730 E:742 ||| JJ
females ||| S:742 E:749 ||| NNS
.  ||| S:749 E:751 ||| .
E1-C  ||| S:751 E:756 ||| NNP
concentrations  ||| S:756 E:771 ||| NNS
were  ||| S:771 E:776 ||| VBD
also  ||| S:776 E:781 ||| RB
inversely  ||| S:781 E:791 ||| RB
associated  ||| S:791 E:802 ||| VBN
with  ||| S:802 E:807 ||| IN
maternal  ||| S:807 E:816 ||| JJ
age  ||| S:816 E:820 ||| NN
( ||| S:820 E:821 ||| -LRB-
P=0.05 ||| S:821 E:827 ||| NNP
) ||| S:827 E:828 ||| -RRB-
.  ||| S:828 E:830 ||| .
E3  ||| S:830 E:833 ||| NNP
was  ||| S:833 E:837 ||| VBD
higher  ||| S:837 E:844 ||| JJR
( ||| S:844 E:845 ||| -LRB-
P  ||| S:845 E:846 ||| NNP
< ||| S:846 E:847 ||| SYM
0.05 ||| S:847 E:851 ||| CD
)  ||| S:851 E:853 ||| -RRB-
in  ||| S:853 E:856 ||| IN
EARLY  ||| S:856 E:862 ||| NNP
than  ||| S:862 E:867 ||| IN
MID  ||| S:867 E:871 ||| NNP
and  ||| S:871 E:875 ||| CC
LATE ||| S:875 E:879 ||| RB
,  ||| S:879 E:881 ||| ,
and  ||| S:881 E:885 ||| CC
higher  ||| S:885 E:892 ||| JJR
overall  ||| S:892 E:900 ||| JJ
for  ||| S:900 E:904 ||| IN
nulliparous  ||| S:904 E:916 ||| NN
than  ||| S:916 E:921 ||| IN
multiparous  ||| S:921 E:933 ||| JJ
females ||| S:933 E:940 ||| NNS
,  ||| S:940 E:942 ||| ,
but  ||| S:942 E:946 ||| CC
concentrations  ||| S:946 E:961 ||| NNS
were  ||| S:961 E:966 ||| VBD
similar  ||| S:966 E:974 ||| JJ
among  ||| S:974 E:980 ||| IN
gestational  ||| S:980 E:992 ||| JJ
stages  ||| S:992 E:999 ||| NNS
when  ||| S:999 E:1004 ||| WRB
parity  ||| S:1004 E:1011 ||| NN
was  ||| S:1011 E:1015 ||| VBD
excluded  ||| S:1015 E:1024 ||| VBN
from  ||| S:1024 E:1029 ||| IN
analyses ||| S:1029 E:1037 ||| NNS
.  ||| S:1037 E:1039 ||| .
Analysis  ||| S:1039 E:1048 ||| NN
by  ||| S:1048 E:1051 ||| IN
indexed  ||| S:1051 E:1059 ||| JJ
month  ||| S:1059 E:1065 ||| NN
post-conception  ||| S:1065 E:1081 ||| NNS
( ||| S:1081 E:1082 ||| -LRB-
IMPC ||| S:1082 E:1086 ||| NNP
)  ||| S:1086 E:1088 ||| -RRB-
demonstrated  ||| S:1088 E:1101 ||| VBN
that  ||| S:1101 E:1106 ||| IN
E1-C  ||| S:1106 E:1111 ||| NNP
increased  ||| S:1111 E:1121 ||| VBD
from  ||| S:1121 E:1126 ||| IN
IMPC  ||| S:1126 E:1131 ||| NNP
9  ||| S:1131 E:1133 ||| CD
and  ||| S:1133 E:1137 ||| CC
peaked  ||| S:1137 E:1144 ||| VBN
at  ||| S:1144 E:1147 ||| IN
IMPC  ||| S:1147 E:1152 ||| NNP
11 ||| S:1152 E:1154 ||| CD
.  ||| S:1154 E:1156 ||| .
E3  ||| S:1156 E:1159 ||| NNP
was  ||| S:1159 E:1163 ||| VBD
significantly  ||| S:1163 E:1177 ||| RB
elevated  ||| S:1177 E:1186 ||| VBD
during  ||| S:1186 E:1193 ||| IN
IMPC  ||| S:1193 E:1198 ||| NNP
1 ||| S:1198 E:1199 ||| CD
,  ||| S:1199 E:1201 ||| ,
decreased  ||| S:1201 E:1211 ||| VBD
until  ||| S:1211 E:1217 ||| IN
IMPC  ||| S:1217 E:1222 ||| NNP
6  ||| S:1222 E:1224 ||| CD
and  ||| S:1224 E:1228 ||| CC
peaked  ||| S:1228 E:1235 ||| VBN
at  ||| S:1235 E:1238 ||| IN
IMPC  ||| S:1238 E:1243 ||| NNP
11 ||| S:1243 E:1245 ||| CD
.  ||| S:1245 E:1247 ||| .
T  ||| S:1247 E:1249 ||| NN
increased  ||| S:1249 E:1259 ||| VBD
( ||| S:1259 E:1260 ||| -LRB-
P  ||| S:1260 E:1261 ||| NNP
< ||| S:1261 E:1262 ||| SYM
0.05 ||| S:1262 E:1266 ||| CD
)  ||| S:1266 E:1268 ||| -RRB-
at  ||| S:1268 E:1271 ||| IN
IMPC  ||| S:1271 E:1276 ||| NNP
3  ||| S:1276 E:1278 ||| CD
and  ||| S:1278 E:1282 ||| CC
continued  ||| S:1282 E:1292 ||| VBD
to  ||| S:1292 E:1295 ||| TO
increase  ||| S:1295 E:1304 ||| VB
throughout  ||| S:1304 E:1315 ||| IN
gestation  ||| S:1315 E:1325 ||| NNS
( ||| S:1325 E:1326 ||| -LRB-
P  ||| S:1326 E:1327 ||| NNP
< ||| S:1327 E:1328 ||| SYM
0.05 ||| S:1328 E:1332 ||| CD
) ||| S:1332 E:1333 ||| -RRB-
.  ||| S:1333 E:1335 ||| .
CORT  ||| S:1335 E:1340 ||| NNP
was  ||| S:1340 E:1344 ||| VBD
higher  ||| S:1344 E:1351 ||| JJR
( ||| S:1351 E:1352 ||| -LRB-
P  ||| S:1352 E:1353 ||| NNP
< ||| S:1353 E:1354 ||| SYM
0.05 ||| S:1354 E:1358 ||| CD
)  ||| S:1358 E:1360 ||| -RRB-
during  ||| S:1360 E:1367 ||| IN
LATE  ||| S:1367 E:1372 ||| RB
compared  ||| S:1372 E:1381 ||| VBN
to  ||| S:1381 E:1384 ||| TO
EARLY  ||| S:1384 E:1390 ||| NNP
and  ||| S:1390 E:1394 ||| CC
MID  ||| S:1394 E:1398 ||| NNP
( ||| S:1398 E:1399 ||| -LRB-
P  ||| S:1399 E:1400 ||| NNP
< ||| S:1400 E:1401 ||| SYM
0.05 ||| S:1401 E:1405 ||| CD
) ||| S:1405 E:1406 ||| -RRB-
,  ||| S:1406 E:1408 ||| ,
peaked  ||| S:1408 E:1415 ||| VBN
during  ||| S:1415 E:1422 ||| IN
IMPC  ||| S:1422 E:1427 ||| NNP
12 ||| S:1427 E:1429 ||| CD
,  ||| S:1429 E:1431 ||| ,
and  ||| S:1431 E:1435 ||| CC
was  ||| S:1435 E:1439 ||| VBD
not  ||| S:1439 E:1443 ||| RB
affected  ||| S:1443 E:1452 ||| VBN
by  ||| S:1452 E:1455 ||| IN
parity ||| S:1455 E:1461 ||| NN
.  ||| S:1461 E:1463 ||| .
Hormone  ||| S:1463 E:1471 ||| JJ
profiles  ||| S:1471 E:1480 ||| NNS
were  ||| S:1480 E:1485 ||| VBD
not  ||| S:1485 E:1489 ||| RB
influenced  ||| S:1489 E:1500 ||| VBN
by  ||| S:1500 E:1503 ||| IN
fetal  ||| S:1503 E:1509 ||| JJ
sex ||| S:1509 E:1512 ||| NN
.  ||| S:1512 E:1514 ||| .
